CVS Stock Chart & Stats
€65.26
€0.44(0.98%)
At close: 4:00 PM EST
€65.26
€0.44(0.98%)
Day’s Range― - ―
52-Week Range€50.05 - €96.90
Previous CloseN/A
Volume168.00
Average Volume (3M)324.00
Market Cap
€121.12B
Enterprise Value€158.57K
Total Cash (Recent Filing)€11.80B
Total Debt (Recent Filing)€78.34B
Price to Earnings (P/E)46.3
Beta0.25
Next Earnings
Aug 05, 2026EPS Estimate
1.62Next Dividend Ex-DateN/A
Dividend Yield2.43%
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume285
30 Day Avg. Volume324
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€97.11Price Target Upside48.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)6.51
Revenue Forecast (FY)€357.67B
Bulls Say, Bears Say
Bulls Say
Cash GenerationSustained operating cash flow (~$10.3B TTM) and solid free cash flow (~$7.4B TTM) provide durable internal funding for debt reduction, strategic investments (tech/AI, Oak Street expansion), dividends and capital expenditures. This cash baseline cushions the business against cyclical medical-cost volatility and supports multi-year execution of margin recovery plans.
Integrated Business ModelVertical integration across Aetna (insurance), Caremark (PBM) and retail/mail/specialty pharmacy creates durable competitive advantages: member retention, internal pharmacy volume capture, coordinated care and cost-management programs. Those cross-segment linkages support durable revenue synergies, stickier customers and control over care pathways that can sustain margins over years.
Aetna Margin RecoveryMaterial AOI improvement at Aetna with MBR down to ~84.6% signals structural underwriting and operational fixes. Management's plan to return to target margins by 2028, plus faster prior-authorization and standardization metrics, indicate sustainable medical-cost control improvements that can permanently lift the Health Care Benefits segment's contribution to enterprise profitability.
Bears Say
Profitability CompressionSubstantial margin erosion over recent years reflects structural pressure from drug pricing, reimbursement and medical-cost trends. Lower net margins and compressed ROE reduce the company's capacity to fund growth and returns without relying on cost cuts or higher-margin business mix shifts, making long-term earnings power more sensitive to adverse reimbursement or utilization shocks.
PBM/Health Services Headwinds & RegulationRebate guarantees, client price improvements and fragmenting state-level regulation are structural risks to PBM economics. Reduced spreads and increased compliance complexity can permanently compress Health Services margins and undermine a core cash and fee engine, limiting long-term profitability and making forecasts more uncertain across payer and provider contracts.
Elevated LeverageAbsolute debt levels remain meaningful even as leverage improves. High gross debt limits flexibility for buybacks or large M&A, increases interest expense sensitivity to rate moves, and forces prioritization of deleveraging over other capital uses. This constrains capital allocation and slows strategic optionality during multi-year margin recovery.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was €50.05 and its highest was €96.90 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is €121.12B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 11 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported €2.257 earnings per share for the quarter, beating the consensus estimate of €1.918 by €0.339.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of €0.585 which represents an annual dividend yield of 2.43%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.62.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of €2.257 in its last earnings report, beating expectations of €1.918. Following the earnings report the stock price went up 4.751%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in DE:CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€97.11 (48.80% Upside)
€97.11 (48.80% Upside)
Blogger Sentiment
Bullish
DE:CVS Sentiment 70%
Sector Average 65%
Sector Average 65%
Insider Transactions
Sold Shares
Worth €283.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
78.30%
12-Months-Change
Fundamentals
Return on Equity
2.43%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
€97.11
▲(48.80% Upside)